Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Corza Medical

HQ: Boulder, CO source · corza.com ↗ · Mountain

FDA-approved therapeutic company Clinical Phase 3

Location: Boulder, CO · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Hemorrhage

1Trials (company is sponsor)

Timeline

Apr 2, 2025 Trial start Phase 3: A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery source ↗

Upcoming milestones

Dec 31, 2026 (ESTIMATED) · Phase 3 · A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery · NCT06664775

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT06664775	A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery	Phase 3	Recruiting	Apr 2, 2025	Dec 31, 2026 (estimated)